Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2023 (1)
  • 2021 (1)
  • 2019 (5)
  • 2018 (1)

Subject

  • Prescription Drugs (4)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Congressional Affairs (1)
  • Diversion Division (1)
  • Outreach/Drug Prevention (1)
  • Press Conferences (1)
  • Synthetic drugs (1)

Drug Name

  • Fentanyl (76)
  • Methamphetamine (46)
  • Cocaine (35)
  • Heroin (23)
  • Marijuana (Cannabis) (15)
  • Synthetic Opioids (8)
  • Opioids (6)
  • Marijuana Concentrates (2)
  • Benzodiazepines (1)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)
  • Oxycodone (9)

Field Division

  • New England (64)
  • Atlanta (50)
  • New York (35)
  • Washington, DC (23)
  • Miami (19)
  • Seattle (15)
  • San Francisco (14)
  • St. Louis (13)
  • Chicago (8)
  • New Jersey (6)
  • New Orleans (6)
  • Dallas (5)
  • Houston (5)
  • El Paso (2)
  • Detroit (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
  • Sede (5)
  • Rocky Mountain (4)
Clear All Results
9 Results - Showing 1 to 9
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
PRESS RELEASE

Denver doctor pleads guilty to illegally prescribing controlled substances

DENVER – United States Attorney Jason R. Dunn announced that Dr. Andrew Mark Ho, age 54, of Denver, pled guilty yesterday to illegally dispensing or illegally causing to be dispensed oxycodone, a controlled substance. Ho pled guilty before Chief U.S. District Court Judge Philip B. Brimmer. Judge Brimmer is scheduled...
PRESS RELEASE

Large-scale poly drug trafficking organization dismantled in Colorado

DENVER – In December of 2018, the Longmont Department of Public Safety Special Enforcement Unit began looking into the drug distribution activities of Joshua Ward, who resided in the city of Longmont. Utilizing various law enforcement investigative techniques, Longmont SEU identified numerous subjects in the northern Colorado region who were...
PRESS RELEASE

Colorado doctor pleads guilty to distributing oxycodone for no legitimate purpose

DENVER – John Van Wu, 49, of Golden, pleaded guilty today to one count of distributing oxycodone outside the usual course of medical practice and for no legitimate purpose, announced U.S. Attorney Jason Dunn and DEA Denver Division Special Agent in Charge William McDermott. The plea was accepted by U.S...
PRESS RELEASE

DEA and U.S. Attorney in the Western District of Louisiana announce settlement with drug distributor

NEW ORLEANS – Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
PRESS RELEASE

Confederated Salish and Kootenai Tribes' Pharmacy settles claims

MISSOULA, Colo. – The Confederated Salish and Kootenai Tribes’ Pharmacy and the U.S. Attorney’s Office have reached an agreement settling alleged pharmacy violations in which the pharmacy will pay a $95,520 civil penalty and take other steps to ensure compliance with federal law and U.S. Drug Enforcement Administration regulations, U.S...
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster